ABBOTINDIA.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 05:59):

Stats
Today's Volume	19 821.00
Average Volume	17 260.00
Market Cap	555.20B
EPS	INR0 ( 2024-01-31 )
Next earnings date	( INR0 ) 2024-05-16
Last Dividend	INR145.00 ( 2023-07-20 )
Next Dividend	INR0 ( N/A )
P/E	48.43
ATR14	INR21.00 (0.08%)

Volume Correlation

Long: -0.09 (neutral)

Short: -0.88 (strong negative)

Signal:(47.979) Neutral

Abbott India Limited Correlation

10 Most Positive Correlations
TANLA.NS	0.888
CSLFINANCE.NS	0.882
KARMAENG.NS	0.872
RAMRAT.NS	0.865
FACT.NS	0.858
ICICIPRULI.NS	0.858
JAYBARMARU.NS	0.855
JITFINFRA.NS	0.854
PATANJALI.NS	0.854
IVC.NS	0.849

10 Most Negative Correlations
CONSUMBEES.NS	-0.92
NIF100BEES.NS	-0.908
DALALSTCOM.NS	-0.884
SRF.NS	-0.884
IEX.NS	-0.867
FLUOROCHEM.NS	-0.859
MPHASIS.NS	-0.858
ANURAS.NS	-0.851
NIITLTD.NS	-0.848
ICICITECH.NS	-0.846

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Abbott India Limited Correlation - Currency/Commodity

0.44
( neutral )

0.62
( weak )

-0.58
( weak negative )

-0.28
( neutral )

0.83
( strong )

0.66
( moderate )

Abbott India Limited Financials

Annual	2022
Revenue:	INR53.49B
Gross Profit:	INR23.74B (44.38 %)
EPS:	INR446.80

Q3	2023
Revenue:	INR14.37B
Gross Profit:	INR6.60B (45.95 %)
EPS:	INR146.35

Q2	2023
Revenue:	INR14.94B
Gross Profit:	INR6.80B (45.50 %)
EPS:	INR147.27

Q1	2023
Revenue:	INR14.79B
Gross Profit:	INR6.55B (44.32 %)
EPS:	INR136.59

Financial Reports:

No articles found.

Abbott India Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR130.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR145.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Abbott India Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.69 - low (55.70%) | Divividend Growth Potential Score: 7.02 - Increase likely (40.33%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR17.50	2008-03-28
Last Dividend	INR145.00	2023-07-20
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	INR821.50	--
Avg. Dividend % Per Year	0.52%	--
Score	2.62	--
Div. Sustainability Score	4.69
Div.Growth Potential Score	7.02
Div. Directional Score	5.85	--

Next Divdend (Est)
(2024-07-17)

INR158.84 Estimate 3.11 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.62

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR5.00	0.08%
2019	INR15.00	0.20%
2020	INR143.00	1.09%
2021	INR155.00	0.98%
2022	INR130.00	0.67%
2023	INR145.00	0.68%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SIYSIL.NS	Dividend Junior	2023-07-24	Semi-Annually	18	1.37%
METROBRAND.NS	Dividend Junior	2023-08-31	Semi-Annually	3	0.18%
HAPPSTMNDS.NS	Dividend Knight	2023-07-06	Semi-Annually	4	0.32%
BDL.NS	Dividend Knight	2023-09-20	Semi-Annually	7	1.17%
PRIMESECU.NS	Dividend Junior	2023-06-06	Sporadic	19	1.83%
KCPSUGIND.NS	Dividend Junior	2023-09-20	Annually	23	0.37%
EKC.NS	Dividend Junior	2023-09-15	Sporadic	19	0.32%
AHLADA.NS	Dividend Junior	2023-09-22	Annually	6	0.95%
SUBROS.NS	Dividend Junior	2023-08-22	Annually	20	0.22%
NATCOPHARM.NS	Dividend Junior	2023-08-22	Semi-Annually	29	0.68%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.199	1.500	6.01	9.02	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.483	1.500	5.74	8.62	[0.1 - 1]
payoutRatioTTM	0.603	-1.000	3.97	-3.97	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	113.56	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	360.54	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	344.67	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.448	1.000	5.87	5.87	[0.2 - 0.8]
operatingProfitMarginTTM	0.270	1.000	6.61	6.61	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.69

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	50.12	1.000	5.04	0	[1 - 100]
returnOnEquityTTM	0.483	2.50	7.26	8.62	[0.1 - 1.5]
freeCashFlowPerShareTTM	344.67	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.537	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	360.54	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0.603	1.500	3.97	-3.97	[0 - 1]
pegRatioTTM	4.09	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.133	1.000	9.17	0	[0.1 - 0.5]
Total Score				7.02

Abbott India Limited

Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, pre-term labor, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.